May 12, 2021 / 03:45PM GMT
Juan Esteban Avendano - BofA Securities, Research Division - Associate
Thank you. Hello. I am Juan Avendano. I am part of the Life Sciences Tools equity research team led by Derik De Bruin at Bank of America. I focus on biopharma services, namely CROs and CDMOs, and I'd like to thank everybody on the webcast for their participation. And please feel free to submit your questions through Veracast. It is a pleasure for me to conduct the following fireside chat with Catalent. We're joined by their current CFO, Wetteny Joseph; incoming CFO, Tom Castellano; as well as Paul Surdez from the Investor Relationships -- Investor Relations.
Gentlemen, thank you once again for your participation.
Wetteny Joseph;CFO -
Thank you, Juan.
Juan Esteban Avendano - BofA Securities, Research Division - Associate
I guess to set the stage, would you like to do a few opening remarks on the company and also talk about the CFO transition that was announced yesterday?
Wetteny Joseph;CFO
Catalent Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript
May 12, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers